AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease
Recruiting now · Not applicable
Conditions studied: Coronary Arterial Disease (CAD)
In brief
A prospective, open-label, multi-site, FIH with up to fifteen (n=15) patients to assess the safety and preliminary effectiveness of the AVS Pulse Intravascular Lithotripsy™ System (Pulse IVL™ System) when used for the treatment of coronary artery disease.
Key facts
- Study ID
- NCT07510438
- Run by
- Amplitude Vascular Systems, Inc.
- People needed
- 15
- Starts
- 2026-05-08
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-05-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Monash Health, Victorian Heart Hospital — Melbourne, Victoria, Australia (enrolling)
- Auckland City Hospital — Auckland, New Zealand (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.